Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia
Authors
Keywords
Early B-cell factor 3, Pediatric acute myeloid leukemia, Methylation, Tumor suppressor, Real-time PCR array
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages 4
Publisher
Springer Nature
Online
2015-01-21
DOI
10.1186/s13046-014-0118-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2014) Lisa Pleyer et al. ANNALS OF HEMATOLOGY
- Comparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemia
- (2014) Rimma Berenstein et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study
- (2014) Haixia Wan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Early Growth Response Genes Regulate B Cell Development, Proliferation, and Immune Response
- (2014) M. Gururajan et al. JOURNAL OF IMMUNOLOGY
- DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies
- (2014) A P Im et al. LEUKEMIA
- High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome
- (2014) Xavier Calvo et al. LEUKEMIA RESEARCH
- Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor
- (2014) Patrick C. G. Haddick et al. PLoS One
- Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
- (2013) O. Abdel-Wahab et al. BLOOD
- The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML)
- (2013) Tao Yan-Fang et al. BMC Medical Genetics
- The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome
- (2013) Connie A. Larsson et al. MOLECULAR CANCER RESEARCH
- Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis
- (2013) Sung-Hoon Park et al. MOLECULES AND CELLS
- Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
- (2012) Yan-Fang Tao et al. BMC CANCER
- Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays
- (2012) Tao Yan-Fang et al. Cancer Cell International
- Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines
- (2012) Zhao Wen-Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DNA methylation as a pathogenic event and as a therapeutic target in AML
- (2011) Till Schoofs et al. CANCER TREATMENT REVIEWS
- Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas
- (2011) S.-M. Hong et al. CLINICAL CANCER RESEARCH
- EBF proteins participate in transcriptional regulation of Xenopus muscle development
- (2011) Yangsook Song Green et al. DEVELOPMENTAL BIOLOGY
- Clinical Implications of Novel Mutations in Epigenetic Modifiers in AML
- (2011) Omar Abdel-Wahab et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma
- (2011) Jin Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663
- (2011) Pan Jian et al. Journal of Hematology & Oncology
- Genetics of Myelodysplastic Syndromes: New Insights
- (2011) T. Graubert et al. Hematology-American Society of Hematology Education Program
- Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies
- (2010) Ulrike Bacher et al. ANNALS OF HEMATOLOGY
- Epigenetics in AML
- (2010) Ari M. Melnick BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- KRAB Zinc Finger Protein ZNF382 Is a Proapoptotic Tumor Suppressor That Represses Multiple Oncogenes and Is Commonly Silenced in Multiple Carcinomas
- (2010) Y. Cheng et al. CANCER RESEARCH
- Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells
- (2010) Liu Meimei et al. MEDICAL ONCOLOGY
- Emerging Roles of the EBF Family of Transcription Factors in Tumor Suppression
- (2009) D. Liao MOLECULAR CANCER RESEARCH
- Frequently Methylated Tumor Suppressor Genes in Head and Neck Squamous Cell Carcinoma
- (2008) K. L. Bennett et al. CANCER RESEARCH
- The ‘zinc knuckle’ motif of Early B cell Factor is required for transcriptional activation of B cell-specific genes
- (2008) Scott Fields et al. MOLECULAR IMMUNOLOGY
- Early B cell factor: Regulator of B lineage specification and commitment
- (2008) Kara Lukin et al. SEMINARS IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now